How drugmakers control distribution to block generic competition

The same strategy that Martin Shkreli used to get away with a 5,000-per cent price increase on an old drug is used by many other drugmakers to maintain sky-high prices on billions of dollars' worth of medications.

from CBC | Health News http://ift.tt/1RKV7oA